52-week price history of KAPA Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Kairos Pharma Ltd’s current trading price is -88.18% away from its 52-week high, while its distance from the 52-week low is 18.25%. The stock’s price range during this period has spanned from $0.40 to $4.00. In the Healthcare sector, the Kairos Pharma Ltd’s shares surpassed a trading volume of approximately 0.81 million for the day, which was noticeably higher compared to the average daily volume of 9.0.43 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Kairos Pharma Ltd (KAPA) has experienced a quarterly decline of -53.63% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 7.97M and boasts a workforce of 4 employees.
Making Sense of Trading Volume and Moving Average Data
Examining KAPA’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for KAPA stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
KAPA Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The metric has seen a significant loss of -68.88% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -70.25%. Over the past 30 days, the price of KAPA has leaped by -40.87%. And in the last five days, it has fallen by -22.46%.
